<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>G. Zarkavelis | Prof. Nikolaos Korfiatis</title><link>https://nkorf.github.io/authors/g.-zarkavelis/</link><atom:link href="https://nkorf.github.io/authors/g.-zarkavelis/index.xml" rel="self" type="application/rss+xml"/><description>G. Zarkavelis</description><generator>HugoBlox Kit (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Thu, 01 Jan 2026 00:00:00 +0000</lastBuildDate><item><title>Phase Ib-II Study of Ramucirumab Combined with Nab-paclitaxel and Gemcitabine as First-line Treatment in Patients With Advanced Pancreatic Adenocarcinoma (RACING)</title><link>https://nkorf.github.io/publications/papaxoinis2026ctrc/</link><pubDate>Thu, 01 Jan 2026 00:00:00 +0000</pubDate><guid>https://nkorf.github.io/publications/papaxoinis2026ctrc/</guid><description/></item></channel></rss>